Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study

Fig. 3

CerMe detection used for triage of hrHPV-positive women with ASC-US/LSIL cytology. A The proportion of pathology types on colposcopy in each of the six cytological diagnoses as well as the PPV of CIN2 + in cytological ASC-US, LSIL, ASC-H, HSIL, and cancer cases of the hrHPV-positive cohort. B CerMe detection as a triage for hrHPV-positive women with ASC-US cytology. C The performance of CerMe detection used as triage for hrHPV-positive women with ASC-US cytology. D CerMe detection as a triage for hrHPV-positive women with LSIL cytology. E The performance of CerMe detection used as triage for hrHPV-positive women with LSIL cytology. hrHPV + , hrHPV positive

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us